Table 1.
Summary Description of Prior Authorization by Plan
| Plan | N of medications subject to prior authorization a |
Earliest date of implementation b |
|---|---|---|
| Low prior authorization plan | ||
| Plan A | 1c | 1/2010 |
| High prior authorization plans | ||
| Plan B | 17 | <2010 |
| Plan C | 74 | <2010 |
| No Prior authorization plans | ||
| Plans D-I | None | Not applicable |
a
Number (N) of medications includes generic, name brand, and combination products
b
date represents first date reported for any medication subjected to PA requirement
c
the single medication was OxyContin.